Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration‐approved drugs

BACKGROUND AND PURPOSE: Macropinocytosis is involved in many pathologies, including cardiovascular disorders, cancer, allergic diseases, viral and bacterial infections. Unfortunately, the currently available pharmacological inhibitors of macropinocytosis interrupt other endocytic processes and have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Lin, Hui‐Ping, Singla, Bhupesh, Ghoshal, Pushpankur, Faulkner, Jessica L, Cherian‐Shaw, Mary, O'Connor, Paul M, She, Jin‐Xiong, Belin de Chantemele, Eric J, Csányi, Gábor
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6109223/
https://ncbi.nlm.nih.gov/pubmed/29953580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14429
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados